69 related articles for article (PubMed ID: 20715931)
21. IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation.
Koesters SA; Alimonti JB; Wachihi C; Matu L; Anzala O; Kimani J; Embree JE; Plummer FA; Fowke KR
Eur J Immunol; 2006 Feb; 36(2):336-44. PubMed ID: 16421946
[TBL] [Abstract][Full Text] [Related]
22. An observational study on patients treated or not for acute HIV infection.
Mussini C; Cozzi-Lepri A; Bedini A; Borghi V; Mongiardo N; Cossarizza A; Esposito R
J Biol Regul Homeost Agents; 2002; 16(1):79-82. PubMed ID: 12003180
[TBL] [Abstract][Full Text] [Related]
23. Reasons given by patients for "non-progression' in HIV infection.
Troop M; Easterbrook P; Thornton S; Flynn R; Gazzard B; Catalan J
AIDS Care; 1997 Apr; 9(2):133-42. PubMed ID: 9135629
[TBL] [Abstract][Full Text] [Related]
24. Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010.
Mandalia S; Westrop SJ; Beck EJ; Nelson M; Gazzard BG; Imami N
PLoS One; 2012; 7(2):e29844. PubMed ID: 22363409
[TBL] [Abstract][Full Text] [Related]
25. Delineation of Homeostatic Immune Signatures Defining Viremic Non-progression in HIV-1 Infection.
Singh AK; Salwe S; Padwal V; Velhal S; Sutar J; Bhowmick S; Mukherjee S; Nagar V; Patil P; Patel V
Front Immunol; 2020; 11():182. PubMed ID: 32194543
[TBL] [Abstract][Full Text] [Related]
26. Western blot banding patterns of HIV rapid progressors in the U.S. Navy Seropositive Cohort: implications for vaccine development. Navy Retroviral Working Group.
Garland FC; Garland CF; Gorham ED; Brodine SK
Ann Epidemiol; 1996 Jul; 6(4):341-7. PubMed ID: 8876845
[TBL] [Abstract][Full Text] [Related]
27. Low Postseroconversion CD4
Palm AA; Lemey P; Jansson M; Månsson F; Kvist A; Szojka Z; Biague A; da Silva ZJ; Rowland-Jones SL; Norrgren H; Esbjörnsson J; Medstrand P
mBio; 2019 Jan; 10(1):. PubMed ID: 30622192
[TBL] [Abstract][Full Text] [Related]
28. Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function.
McDonald RA; Mayers DL; Chung RC; Wagner KF; Ratto-Kim S; Birx DL; Michael NL
J Virol; 1997 Mar; 71(3):1871-9. PubMed ID: 9032317
[TBL] [Abstract][Full Text] [Related]
29. [Study on the difference of the APOBEC3G mRNA levels among HIV long-term nonprogressors, slow progressors, people at high risks and normal people].
Liu YJ; Li L; Bao ZY; Liu SY; Zhuang DM; Li HP; Li JY
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Apr; 29(4):356-9. PubMed ID: 18843993
[TBL] [Abstract][Full Text] [Related]
30. Mycoplasma species in rapid and slow HIV progressors.
Ainsworth JG; Hourshid S; Easterbrook PJ; Gilroy CB; Weber JN; Taylor-obinson D
Int J STD AIDS; 2000 Feb; 11(2):76-9. PubMed ID: 10678473
[TBL] [Abstract][Full Text] [Related]
31. Alterations in B Cell Compartment Correlate with Poor Neutralization Response and Disease Progression in HIV-1 Infected Children.
Aggarwal H; Khan L; Chaudhary O; Kumar S; Makhdoomi MA; Singh R; Sharma K; Mishra N; Lodha R; Srinivas M; Das BK; Kabra SK; Luthra K
Front Immunol; 2017; 8():1697. PubMed ID: 29250072
[TBL] [Abstract][Full Text] [Related]
32. Low CD4 counts rather than superantigenic-like effects account for differences in expressed T-cell receptor (TCR) repertoires between HIV-1 seropositive long-term non-progressors and individuals with progressive disease.
Westby M; Vaughan AN; Balotta C; Galli M; Clerici M; Dalgleish AG
Br J Haematol; 1998 Sep; 102(5):1187-96. PubMed ID: 9753044
[TBL] [Abstract][Full Text] [Related]
33. How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS).
Petrucci A; Dorrucci M; Alliegro MB; Pezzotti P; Rezza G; Sinicco A; Lazzarin A; Angarano G
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Mar; 14(3):243-8. PubMed ID: 9117457
[TBL] [Abstract][Full Text] [Related]
34. The CpG dinucleotide content of the HIV-1 envelope gene may predict disease progression.
Wasson MK; Borkakoti J; Kumar A; Biswas B; Vivekanandan P
Sci Rep; 2017 Aug; 7(1):8162. PubMed ID: 28811638
[TBL] [Abstract][Full Text] [Related]
35. High APRIL Levels Are Associated With Slow Disease Progression and Low Immune Activation in Chronic HIV-1-Infected Patients.
Liu Y; Li X; Han Y; Qiu Z; Song X; Li B; Zhang H; Wang H; Feng K; Liu L; Wang J; Sun M; Li T
Front Med (Lausanne); 2020; 7():299. PubMed ID: 32850873
[No Abstract] [Full Text] [Related]
36. A Cytokine Pattern That Differentiates Preseroconversion From Postseroconversion Phases of Primary HIV Infection.
Pastor L; Parker E; Carrillo J; Urrea V; Fuente-Soro L; Respeito D; Jairoce C; Mandomando I; Blanco J; Naniche D
J Acquir Immune Defic Syndr; 2017 Apr; 74(4):459-466. PubMed ID: 28225519
[TBL] [Abstract][Full Text] [Related]
37. Impact of epidemic and individual heterogeneity on the population distribution of disease progression rates. An example from patient populations in trials of human immunodeficiency virus infection.
Ioannidis JP; Cappelleri JC; Schmid CH; Lau J
Am J Epidemiol; 1996 Dec; 144(11):1074-85. PubMed ID: 8942440
[TBL] [Abstract][Full Text] [Related]
38. Altered lipid metabolites accelerate early dysfunction of T cells in HIV-infected rapid progressors by impairing mitochondrial function.
Li SY; Yin LB; Ding HB; Liu M; Lv JN; Li JQ; Wang J; Tang T; Fu YJ; Jiang YJ; Zhang ZN; Shang H
Front Immunol; 2023; 14():1106881. PubMed ID: 36875092
[TBL] [Abstract][Full Text] [Related]
39. Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy.
Huang X; Liu X; Meyers K; Liu L; Su B; Wang P; Li Z; Li L; Zhang T; Li N; Chen H; Li H; Wu H
Sci Rep; 2016 Nov; 6():36234. PubMed ID: 27830756
[TBL] [Abstract][Full Text] [Related]
40. Long-term non-progression in HIV infection: definitions and epidemiological issues.
Easterbrook PJ
J Infect; 1999 Mar; 38(2):71-3. PubMed ID: 10342644
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
